MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Ariad Pharmaceuticals Company Profile (NASDAQ:ARIA)

Consensus Ratings for Ariad Pharmaceuticals (NASDAQ:ARIA) (?)
Ratings Breakdown: 1 Sell Rating(s), 3 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.50)
Consensus Price Target: $9.00 (25.35% upside)

Analysts' Ratings History for Ariad Pharmaceuticals (NASDAQ:ARIA)
Show:
DateFirmActionRatingPrice TargetActions
4/19/2016JMP SecuritiesReiterated RatingOutperform$9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/17/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/11/2016JPMorgan Chase & Co.Reiterated RatingOutperform$11.00 -> $9.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/25/2016RBC CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/22/2016Goldman SachsLower Price Target$7.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/19/2016BarclaysInitiated CoverageUnderweight$6.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/26/2015William BlairReiterated RatingOutperform$11.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015HC WainwrightReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2015BMO Capital MarketsReiterated RatingOutperform$14.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2015Stifel NicolausReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/11/2014Credit SuisseDowngradeNeutral -> Underperform$8.00 -> $6.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/6/2014Chardan CapitalReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/8/2014Citigroup Inc.Reiterated RatingSell$7.00 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/2/2014Jefferies GroupReiterated RatingPositiveView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 4/30/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha